MENU
AMRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Amarin (AMRN) Ownership - Who owns Amarin?

Amarin Corp PLC is a biopharmaceutical company... Show more

Profile

Industry
Pharmaceuticals Other
Address
112-114 St Stephens Green
Phone
+353 16699020
Employees
275
Web
https://www.amarincorp.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
351.19M
P/E Ratio
N/A
Total Cash
286.59M
Projected Growth
N/A
Total Debt
6.73M
Revenue
226.73M
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash/Share
13.78
Total Debt/Equity
N/A
Revenue/Share
10.96 USD as % of share price

Fundamentals

AMRN
Capitalization
351M
P/E Ratio
N/A
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash
287M
Total Cash/Share
13.78
Total Debt
6.73M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
10.96%
Revenue
227M
ROE
N/A
Book Value
459M
P/B Ratio
0.77
Cash Flow
N/A
Earnings
-4.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
310M
Current Ratio
3.45
Current Revenue Per Employee
180618.19
Dividends Per Share - Security
N/A
EBITDA
-46.54M
Float
N/A
Float - Current
N/A
Gross Income Margin
44.71
Revenue To Assets
-12.22
Shares Held By Institutions
56.1M
Shares Outstanding - Current
20.8M
Total Liabilities
201M
Total Volume MTD
N/A
Value
-1
Gain YTD
74.124
View a ticker or compare two or three
AMRN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on commercialization and development of therapeutics to improve cardiovascular health

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
112-114 St Stephens Green
Phone
+353 16699020
Employees
275
Web
https://www.amarincorp.com